Public relations (PR) Articles

RSS | Login | Register

Ketchum names new healthcare head

Matthew Arnold September 01, 2007

Ketchum named Ann Moravick EVP and director, global healthcare and brand advocacy.

Pfizer unveils new consumer Web site

Stephen McGuire August 14, 2007

Pfizer has launched a refreshed consumer Web site at www.pfizer.com featuring a cleaner design and new features.

Moravick takes over as Ketchum healthcare head

Matthew Arnold August 14, 2007

Ketchum named Ann Moravick EVP and director, global healthcare and brand advocacy.

Lilly may extend grant disclosure policy globally

Marc Iskowitz August 13, 2007

Eli Lilly said it is studying the feasibility of extending its grants disclosure policy globally and could do so by next year.

Cipla quarrels with AIDS activists on price of drug

Marc Iskowitz August 10, 2007

Accusations by AIDS advocates regarding the policies of Indian drugmaker Cipla have led to a full-on dust-up between the two.

Mirapex campaign gets kick from research

Marc Iskowitz July 23, 2007

Boehringer Ingelheims DTC campaign for Mirapex broke last week, days after scientists reported a genetic basis for restless leg syndrome, helping legitimize the disorder.

China executes ex-state FDA head amid product safety crisis

Stephen McGuire July 11, 2007

China executed its former top food and drug administration regulator on Tuesday, sending a strong message that it is serious about tackling its product safety crisis.

Agency A-to-Z

July 01, 2007

The indispensable guide to healthcare agencies, including contact details, rosters, wins, losses and examples of creative work. Firms submitted their own data as part of MMM’s annual agency review.

PR View by Marita Gomez

Marita Gomez July 01, 2007

I sat in a meeting recently listening to two agencies bicker about which will shrivel up first in the next decade—advertising or PR.

Pharmas not ‘Sicko’ with worry over Moore movie

Matthew Arnold July 01, 2007

On the eve of the June 29 debut of Sicko, Michael Moore’s broadside against American healthcare, pharma communicators were wary but optimistic that his latest work would prove more bark than bite.

« Previous

Most Emailed

Most Recent

RSS